Page 27 - The clinical aspects and management of chronic migraine Judith Anne Pijpers

23. Lipton RB, Bigal ME, Ashina S, et al. Cutaneous allodynia in the migraine population. Ann Neurol. 2008;63(2):148-158. doi:10.1002/ana.21211
24. Louter MA, Bosker JE, van Oosterhout WPJ, et al. Cutaneous allodynia as a predictor of migraine chronification. Brain. 2013;136(11):3489-3496. doi:10.1093/brain/awt251
25. Bigal ME, Ashina S, Burstein R, et al. Prevalence and characteristics of allodynia in headache sufferers: a population study. Neurology. 2008;70(17):1525-1533. doi:10.1212/01.wnl.0000310645.31020.b1
26. Schwedt TJ, Larson-Prior L, Coalson RS, et al. Allodynia and descending pain modulation in migraine: a resting state functional connectivity analysis. Pain Med. 2014;15(1):154-165. doi:10.1111/ pme.12267
27. Schulte LH, Allers A, May A. Hypothalamus as a mediator of chronic migraine. Neurology. 2017:10.1212/WNL.0000000000003963. doi:10.1212/WNL.0000000000003963
28. Louter M, Wardenaar K, Veen G, et al. Allodynia is associated with a higher prevalence of depression in migraine patients. Cephalalgia. 2014;34(14):1187-1192. doi:10.1177/0333102414532554
29. Buse DC, Greisman JD, Baigi K, Lipton RB. Migraine Progression: A Systematic Review. Headache J Head Face Pain. 2019;59(3):306-338. doi:10.1111/head.13459
30. Schwedt TJ. Chronic migraine. Bmj. 2014;348(mar 24 5):g1416. doi:10.1136/bmj.g1416
31. Pelzer N, Louter MA, van Zwet EW, et al. Linking migraine frequency with family history of migraine.
Cephalalgia. 2019;39(2):229-236. doi:10.1177/0333102418783295
32. De Felice M, Ossipov MH, Wang R, et al. Triptan-induced latent sensitization a possible basis for
medication overuse headache. Ann Neurol. 2010;67(3):325-337. doi:10.1002/ana.21897
33. Westergaard ML, Munksgaard SB, Bendtsen L, Jensen RH. Medication-overuse headache: a
perspective review. Ther Adv Drug Saf Rev. 2016;7(4):147-158. doi:10.1177/2042098616653390
34. Bijl R V., Ravelli A, van Zessen G. Prevalence of psychiatric disorder in the general population: results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatry Psychiatr
Epidemiol. 1998;33(12):587-595. doi:10.1007/s001270050098
35. Bennett S, Thomas AJ. Depression and dementia: Cause, consequence or coincidence? Maturitas.
2014;79(2):184-190. doi:10.1016/j.maturitas.2014.05.009
36. Zhu K, van Hilten JJ, Marinus J. Associated and predictive factors of depressive symptoms in
patients with Parkinson’s disease. J Neurol. 2016;263(6):1215-1225. doi:10.1007/s00415-016-8130-3
37. Corallo F, Lo Buono V, Genovese R, et al. A complex relation between depression and multiple
sclerosis: a descriptive review. Neurol Sci. April 2019. doi:10.1007/s10072-019-03889-1
38. Sheng J, Liu S, Wang Y, Cui R, Zhang X. The Link between Depression and Chronic Pain: Neural
Mechanisms in the Brain. Neural Plast. 2017;2017:1-10. doi:10.1155/2017/9724371
39. Breslau N, Lipton RB, Stewart WF, Schultz LR, Welch KMA. Comorbidity of migraine and depression: Investigating potential etiology and prognosis. Neurology. 2003;60(8):1308-1312. doi:10.1212/01.
WNL.0000058907.41080.54
40. Stam AH, De Vries B, Janssens ACJW, et al. Shared genetic factors in migraine and depression: Evidence
from a genetic isolate. Neurology. 2010;74(4):288-294. doi:10.1212/WNL.0b013e3181cbcd19
41. Schur EA, Noonan C, Buchwald D, Goldberg J, Afari N. A Twin Study of Depression and Migraine: Evidence for a Shared Genetic Vulnerability. Headache J Head Face Pain. 2009;49(10):1493-1502.
doi:10.1111/j.1526-4610.2009.01425.x
42. Anttila V, Bulik-Sullivan B, Finucane HK, et al. Analysis of shared heritability in common disorders of
the brain. Science (80- ). 2018;360(6395):eaap8757. doi:10.1126/science.aap8757
43. Bottiroli S, Viana M, Sances G, et al. Psychological factors associated with failure of detoxification treatment in chronic headache associated with medication overuse. Cephalalgia. 2016;36(14):1356-
1365. doi:10.1177/0333102416631960
44. Lampl C, Thomas H, Tassorelli C, Katsarava Z, Laínez JM. Headache , depression and anxiety :
associations in the Eurolight project. J Headache Pain. 2016. doi:10.1186/s10194-016-0649-2
45. Dresler T, Caratozzolo S, Guldolf K, et al. Understanding the nature of psychiatric comorbidity in migraine: a systematic review focused on interactions and treatment implications. J Headache Pain.
2019;20(1):51. doi:10.1186/s10194-019-0988-x
46. Evers S, Marziniak M. Clinical features, pathophysiology, and treatment of medication-overuse
headache. Lancet Neurol. 2010;9(4):391-401. doi:10.1016/S1474-4422(10)70008-9
47. Kristoffersen ES, Lundqvist C. Medication-overuse headache: epidemiology, diagnosis and
treatment. Ther Adv Drug Saf. 2014;5(2):87-99. doi:10.1177/2042098614522683
48. Dindo L, Recober A, Marchman J, O’Hara M, Turvey C. Depression and Disability in Migraine: The Role of Pain Acceptance and Values-Based Action. Int J Behav Med. 2014:1-9. doi:10.1007/s12529-
014-9390-x
1
General introduction
25